Allergy/Imm Medical News about allergic rhinitis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Novel therapies for children with severe asthma

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treatment of seasonal allergic rhinitis
Annals of Allergy, Asthma, and Immunology, 08/03/09

LaForce C et al. – Ciclesonide hydrofluoroalkane nasal aerosol demonstrated statistically significant improvements in SAR symptoms vs placebo. On the basis of comparable efficacy and safety profiles observed for all doses, these results suggest that the 75–micro g and 150–micro g doses of ciclesonide hydrofluoroalkane appear appropriate for further evaluation of efficacy.

<< Previous
A case study of ex ante, value-based price and reimbursement...

Next >>
Efficacy and Safety of Privigen in Children and Adolescents With...

Time Interval and the Factors Associated with the Development of Asthma in Patients with Allergic Rhinitis
Lung, 10/09/09 Relevance Score: 69%

Nonallergic Rhinitis Symptoms More Severe Than Allergic Rhinitis
ScienceDaily, 10/06/09 Relevance Score: 69%

Allergic rhinitis, histamine, and otitis media
Allergy and Asthma Proceedings, 10/09/09 Relevance Score: 68%

Trichuris suis ova therapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial
Journal of Allergy and Clinical Immunology, 10/07/09 Relevance Score: 68%

Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis
Clinical and Experimental Immunology, 10/05/09 Relevance Score: 68%